Agilon Health Sees Q2 Sales $1.435B-$1.475B vs $1.343B Est

Benzinga Newsdesk www.benzinga.com Positive 82.4%

Neg 0% Neu 0% Pos 82.4%

Agilon Health (NYSE:AGL) sees Q2 sales of $1.435 billion-$1.475 billion vs $1.343 billion analyst estimate.

Comments

No comments yet. Be the first!